Associations of the COVID-19 pandemic with the reported incidence of important endemic infectious disease agents and syndromes in Pakistan.
COVID-19
Incidence
Infectious disease outbreaks
SARS-CoV-2
Journal
BMC infectious diseases
ISSN: 1471-2334
Titre abrégé: BMC Infect Dis
Pays: England
ID NLM: 100968551
Informations de publication
Date de publication:
26 Nov 2022
26 Nov 2022
Historique:
received:
31
03
2022
accepted:
10
11
2022
entrez:
26
11
2022
pubmed:
27
11
2022
medline:
30
11
2022
Statut:
epublish
Résumé
Persons in Pakistan have suffered from various infectious diseases over the years, each impacted by various factors including climate change, seasonality, geopolitics, and resource availability. The COVID-19 pandemic is another complicating factor, with changes in the reported incidence of endemic infectious diseases and related syndromes under surveillance. We assessed the monthly incidence of eight important infectious diseases/syndromes: acute upper respiratory infection (AURI), viral hepatitis, malaria, pneumonia, diarrhea, typhoid fever, measles, and neonatal tetanus (NNT), before and after the onset of the COVID-19 pandemic. Administrative health data of monthly reported cases of these diseases/syndromes from all five provinces/regions of Pakistan for a 3-year interval (March 2018-February 2021) were analyzed using an interrupted time series approach. Reported monthly incidence for each infectious disease agent or syndrome and COVID-19 were subjected to time series visualization. Spearman's rank correlation coefficient between each infectious disease/syndrome and COVID-19 was calculated and median case numbers of each disease before and after the onset of the COVID-19 pandemic were compared using a Wilcoxon signed-rank test. Subsequently, a generalized linear negative binomial regression model was developed to determine the association between reported cases of each disease and COVID-19. In late February 2020, concurrent with the start of COVID-19, in all provinces, there were decreases in the reported incidence of the following diseases: AURI, pneumonia, hepatitis, diarrhea, typhoid, and measles. In contrast, the incidence of COVID was negatively associated with the reported incidence of NNT only in Punjab and Sindh, but not in Khyber Pakhtunkhwa (KPK), Balochistan, or Azad Jammu & Kashmir (AJK) & Gilgit Baltistan (GB). Similarly, COVID-19 was associated with a lowered incidence of malaria in Punjab, Sindh, and AJK & GB, but not in KPK and Balochistan. COVID-19 was associated with a decreased reported incidence of most infectious diseases/syndromes studied in most provinces of Pakistan. However, exceptions included NNT in KPK, Balochistan and AJK & GB, and malaria in KPK and Balochistan. This general trend was attributed to a combination of resource diversion, misdiagnosis, misclassification, misinformation, and seasonal patterns of each disease.
Sections du résumé
BACKGROUND
BACKGROUND
Persons in Pakistan have suffered from various infectious diseases over the years, each impacted by various factors including climate change, seasonality, geopolitics, and resource availability. The COVID-19 pandemic is another complicating factor, with changes in the reported incidence of endemic infectious diseases and related syndromes under surveillance.
METHODS
METHODS
We assessed the monthly incidence of eight important infectious diseases/syndromes: acute upper respiratory infection (AURI), viral hepatitis, malaria, pneumonia, diarrhea, typhoid fever, measles, and neonatal tetanus (NNT), before and after the onset of the COVID-19 pandemic. Administrative health data of monthly reported cases of these diseases/syndromes from all five provinces/regions of Pakistan for a 3-year interval (March 2018-February 2021) were analyzed using an interrupted time series approach. Reported monthly incidence for each infectious disease agent or syndrome and COVID-19 were subjected to time series visualization. Spearman's rank correlation coefficient between each infectious disease/syndrome and COVID-19 was calculated and median case numbers of each disease before and after the onset of the COVID-19 pandemic were compared using a Wilcoxon signed-rank test. Subsequently, a generalized linear negative binomial regression model was developed to determine the association between reported cases of each disease and COVID-19.
RESULTS
RESULTS
In late February 2020, concurrent with the start of COVID-19, in all provinces, there were decreases in the reported incidence of the following diseases: AURI, pneumonia, hepatitis, diarrhea, typhoid, and measles. In contrast, the incidence of COVID was negatively associated with the reported incidence of NNT only in Punjab and Sindh, but not in Khyber Pakhtunkhwa (KPK), Balochistan, or Azad Jammu & Kashmir (AJK) & Gilgit Baltistan (GB). Similarly, COVID-19 was associated with a lowered incidence of malaria in Punjab, Sindh, and AJK & GB, but not in KPK and Balochistan.
CONCLUSIONS
CONCLUSIONS
COVID-19 was associated with a decreased reported incidence of most infectious diseases/syndromes studied in most provinces of Pakistan. However, exceptions included NNT in KPK, Balochistan and AJK & GB, and malaria in KPK and Balochistan. This general trend was attributed to a combination of resource diversion, misdiagnosis, misclassification, misinformation, and seasonal patterns of each disease.
Identifiants
pubmed: 36435768
doi: 10.1186/s12879-022-07869-3
pii: 10.1186/s12879-022-07869-3
pmc: PMC9701436
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
887Informations de copyright
© 2022. The Author(s).
Références
Clin Infect Dis. 2020 Dec 1;71(Suppl 3):S319-S335
pubmed: 33258941
BMC Infect Dis. 2018 Aug 22;18(1):413
pubmed: 30134861
J Med Virol. 2021 Jan;93(1):80-82
pubmed: 32510175
Expert Rev Pharmacoecon Outcomes Res. 2020 Aug;20(4):343-354
pubmed: 32530725
J Med Virol. 2021 May;93(5):2573-2575
pubmed: 33295641
J Med Virol. 2021 Apr;93(4):1875-1877
pubmed: 33230888
J Infect Dev Ctries. 2020 Aug 31;14(8):823-835
pubmed: 32903224
Am J Trop Med Hyg. 2021 Aug 30;105(5):1144-1147
pubmed: 34460426
Asia Pac J Public Health. 2012 Jul;24(4):586-94
pubmed: 22593215
Lancet. 2013 Jun 22;381(9884):2138-40
pubmed: 23684256
Travel Med Infect Dis. 2021 May-Jun;41:102011
pubmed: 33711424
Int J Health Plann Manage. 2020 Sep;35(5):1041-1054
pubmed: 32700410
Eur J Med Res. 2021 Jul 3;26(1):67
pubmed: 34217366
Trop Med Health. 2022 Jul 19;50(1):46
pubmed: 35850780
Lancet. 2019 Sep 14;394(10202):915-916
pubmed: 31526731
J Multidiscip Healthc. 2022 Jan 11;15:21-45
pubmed: 35046661
Infect Ecol Epidemiol. 2021 Jan 20;11(1):1873494
pubmed: 33537119
Trop Med Health. 2022 Feb 25;50(1):18
pubmed: 35216627
J Med Virol. 2021 Jan;93(1):184-186
pubmed: 32648942
Ther Adv Vaccines Immunother. 2022 Jul 5;10:25151355221107975
pubmed: 35832726
Trop Med Infect Dis. 2020 Sep 06;5(3):
pubmed: 32899935
Int J Infect Dis. 2012 Dec;16(12):e833-42
pubmed: 22940280
Front Med (Lausanne). 2020 Aug 13;7:526
pubmed: 32903492
Lancet Glob Health. 2020 Dec;8(12):e1453-e1454
pubmed: 33188730
Front Public Health. 2022 Mar 09;10:803937
pubmed: 35356012
Malar J. 2020 Dec 7;19(1):452
pubmed: 33287809
Clin Epidemiol Glob Health. 2021 Oct-Dec;12:100841
pubmed: 34368503
J Med Virol. 2021 Jul;93(7):4065-4067
pubmed: 33200437
Global Health. 2021 Jan 5;17(1):4
pubmed: 33402169
Ther Adv Vaccines Immunother. 2022 Feb 10;10:25151355221077658
pubmed: 35174312
Trop Med Health. 2021 Dec 29;49(1):101
pubmed: 34963494
Epidemiol Infect. 2022 Feb 22;150:e41
pubmed: 35190004
Am J Trop Med Hyg. 2020 Aug;103(2):603-604
pubmed: 32588810
Ann Med Surg (Lond). 2022 May 26;78:103869
pubmed: 35734670
Int J Health Plann Manage. 2022 Jul;37(4):1907-1911
pubmed: 35340058
JMIR Public Health Surveill. 2021 May 19;7(5):e28517
pubmed: 33877048
Cureus. 2018 Nov 5;10(11):e3551
pubmed: 30648083
Health Secur. 2017 May/Jun;15(3):268-281
pubmed: 28636447